DCF — BAYAMON MEDICAL CENTER
Enterprise Value: $-11.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-11.2M
Enterprise Value
$-5.6M
PV of Cash Flows
$-5.5M
PV of Terminal Value
$-8.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $84.1M | $1.0M | 1.0% | $-2.6M | $-2.4M |
| Year 2 | $86.6M | $1.9M | 2.0% | $-1.8M | $-1.5M |
| Year 3 | $89.2M | $2.8M | 3.0% | $-1.1M | $-0.8M |
| Year 4 | $91.9M | $3.3M | 4.0% | $-0.8M | $-0.5M |
| Year 5 | $94.7M | $3.7M | 4.0% | $-0.7M | $-0.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-11.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$81.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.006449145456353804
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5